Results 111 to 120 of about 103,286 (345)

Research progress on the use of the optical coherence tomography system for the diagnosis and treatment of central nervous system tumors

Ibrain, Volume 11, Issue 1, Page 3-18, Spring 2025.
With the advantages of high‐resolution imaging, efficient image acquisition, intraoperative real‐time detection, and radiation‐free and noninvasive characteristics, optical coherence tomography (OCT) provides accurate diagnosis and effective intraoperative guidance for the minimally invasive diagnosis and treatment of central nervous system (CNS ...
Jiuhong Li, Ziba Ayi, Gonggong Lu, Haibo Rao, Feilong Yang, Jing Li, Jiachen Sun, Junlin Lu, Xulin Hu, Si Zhang, Xuhui Hui   +10 more
wiley   +1 more source

dlabella29/MeningiomaAnalysis: Meningioma Volume Analysis

<p>This tool is used to calculate the volume of meningioma gross tumor volume in both a skull stripped image and a face-anonymized image.
Dominic LaBella
core   +1 more source

New‐Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank

International Journal of Cancer, EarlyView.
ABSTRACT The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly in China and is linked to increased cancer risk, but causality remains unclear due to biases. We examined the causal effect of T2DM on cancer risk using bias‐minimizing methods.
Mengying Wang, Owen Tipping, Bowen Liu, Derrick A. Bennett, Baiyong Shen, Siyi Zou, Shulin Zhao, Richard M. Martin, Matthew Sperrin, Andrew G. Renehan   +9 more
wiley   +1 more source

Early Postoperative Adverse Events (≤ 30 Days) in Spinal Oncology: Defining the Incidence, Severity, and Predictors in a Mixed Prospective Cohort Including Intradural and Metastatic Spinal Tumors

International Journal of Cancer, EarlyView.
ABSTRACT Complication reporting in spinal tumor surgery remains inconsistently defined. We aimed to quantify the incidence, severity, and spectrum of early (≤ 30 days) postoperative adverse events (AEs) in spinal tumor surgery and to identify predictors of overall and serious complications using standardized severity grading.
Meltem Ivren, Philip Dao Trong, Maximilian Klass, Martin Dugas, Sebastian Ille, Sandro M. Krieg, Pavlina Lenga   +6 more
wiley   +1 more source

Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth

Neurobiology of Disease, 2008
Meningiomas, common tumors arising from arachnoidal cells of the meninges, may occur sporadically, or in association with the inherited disorder, neurofibromatosis 2 (NF2).
Marianne F. James, Johanna M. Lelke, Mia MacCollin, Scott R. Plotkin, Anat O. Stemmer-Rachamimov, Vijaya Ramesh, James F. Gusella   +6 more
doaj   +1 more source

Paradoxical evolution of spheno-orbital meningioma after cessation of progestin treatment

BACKGROUND: Meningioma is the most frequent primary benign intracranial tumor, with a higher incidence in women. Treatment with progesterone acetates, including cyproterone, nomegestrol, chlormadinone, promegestone, medrogestone, and medroxyprogesterone ...
Chapelle, Anne-Catherine, Moïse, Martin, Bouchain, Olivier, Andris, Cécile, Lebeau, Julie, Bianchi, Elettra, Pintiaux, Axelle, Steinmetz, Maximilien, Reuter, Gilles   +8 more
core   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma

Neuro-Oncology, 2018
Background Meningiomas are mostly benign tumors tending to progress to higher-grade lesions. Mutations in the telomerase reverse transcriptase (TERT) gene promoter are comparably rare in meningioma, but were recently suggested to predict risk of ...
S. Spiegl-Kreinecker, D. Lötsch, K. Neumayer, L. Kastler, J. Gojo, C. Pirker, J. Pichler, S. Weis, Rajiv Kumar, G. Webersinke, A. Gruber, W. Berger   +11 more
semanticscholar   +1 more source

Deep‐Learning Based Contrast Boosting: A Multi‐Center Multi‐Reader Study on Clinical Performance With Standard Contrast Enhanced Brain MRI

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Gadolinium‐based contrast agents are used in brain MRI to improve the visualization of disorders and improve the delineation of lesions. Higher doses of GBCAs can improve lesion sensitivity but may have safety implications, particularly in light of recent findings on gadolinium retention and deposition.
Srivathsa Pasumarthi Venkata, Thomas Campbell Arnold, Sonia Colombo Serra, Jeffrey. D. Rudie, Jalal. B. Andre, Ronny Elor, Dayang Wang, Praveen Gulaka, Ajit Sankaranarayanan, Gunter Erb, Greg Zaharchuk   +10 more
wiley   +1 more source

Efficient ADCC- killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK.

JCI Insight, 2019
Meningiomas are the most common adult primary tumor of the central nervous system, but there are no known effective medical therapies for recurrent meningioma, particularly for WHO grade II and III tumors.
Amber J. Giles, Shu-Yu Hao, M. Padget, Hua Song, Wei Zhang, John P. Lynes, Victoria E. Sanchez, Yang Liu, Jinkyu Jung, Xiaoyu Cao, Rika Fujii, R. Jensen, D. Gillespie, J. Schlom, M. Gilbert, E. Nduom, Chun-Zhang Yang, John H. Lee, P. Soon-Shiong, J. Hodge, Deric M. Park   +20 more
semanticscholar   +1 more source